Glaukos
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Glaukos and other ETFs, options, and stocks.About GKOS
Glaukos Corp. is an ophthalmic medical technology and pharmaceutical company, which focuses on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It engages in development and commercialization of therapies across several end markets within ophthalmology.
GKOS Key Statistics
Stock Snapshot
With a market cap of 9B, Glaukos(GKOS) trades at $152.96. The stock has a price-to-earnings ratio of -46.47.
As of 2026-07-09, Glaukos(GKOS) stock has fluctuated between $149.45 and $154.12. The current price stands at $152.96, placing the stock +2.3% above today's low and -0.8% off the high.
The Glaukos(GKOS)'s current trading volume is 1.04M, compared to an average daily volume of 1.03M.
During the past year, Glaukos(GKOS) stock moved between $73.16 at its lowest and $154.61 at its peak.
During the past year, Glaukos(GKOS) stock moved between $73.16 at its lowest and $154.61 at its peak.
GKOS News
In late June 2026, Glaukos Corporation announced it had fully enrolled 275 patients in a Phase 2 trial of GLK-321, a cream-based eyelid therapy using its iLutio...
Should you stick with a diversified healthcare titan or a specialized high-growth challenger? Here is how Abbott Laboratories (ABT 0.70%) and Glaukos (GKOS +1.5...
Analyst ratings
100%
of 14 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.